Page 21 - Pharma Industry

Cough syrup makers see healthy future, say controversies won't dent demand

Pharma industry insiders claimed that most contamination-related problems arise due to solvents

Pharma industry says taking steps to check misuse of codeine drugs

Sales declining anyway and there is no need to ban because of alleged misuse, say experts

Centre looking to phase out codeine-based cough syrups, select FDCs

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants

Indian generic formulation-makers level of capex declining: Candle Partners

Candle Partners study shows that from the peak of 30% of gross block in FY16, the capex is down to 9-10% of gross block

Essential medicines list updated, adds 34 new drugs and drops 26

Medicines to treat diabetes, HIV, TB, contraceptives, hormonal medicines included in National List of Essential Medicines

Indian pharma industry eyes South American market, seeks greater access

As Global pharma majors are exiting South America post Covid, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) is looking to promote Indian pharmaceutical exports in the LAC

Bayer brings kidney disease treatment drug to India at 1/15th US cost

Brand named Kerendia (finerenone) will cost Rs 97.5 per day as treatment cost in India

Top Headlines: FPIs cut stake in BSE firms, pharma eyes $400 bn turnover

The Centre's recent move to impose GST on services rendered by the markets regulator, Securities and Exchange Board of India (Sebi), has rattled FPIs

100-year road map: Pharma industry eyes $400-billion turnover by 2047

The industry is now talking about breaking into the top-10 countries in terms of value by 2030, and entering the top-5 club by 2047

Start-ups collaborate with chemists, shake up offline pharma business

Some are managing supply-chain backend for retail pharmacies, right from stockist to chemist, others are offering telemedicine kiosks at chemist outlets, and digitising pharmacies

Results preview: Pharma margins likely to remain under pressure in Q1

Hospitals back to normalcy; tough road ahead for diagnostics

Time for Indian pharma industry to move to value leadership: Mandaviya

Time has come for the Indian pharmaceuticals industry to move from 'volume' to 'value' leadership to capture global market and the government is committed to supporting companies with industry-friendly policies, Union minister Mansukh Mandaviya said on Saturday. Addressing an interactive session with Indian Pharmaceutical Alliance, the Minister for Chemicals & Fertilizers and Health & Family Welfare also asked the homegrown firms to learn from global best practices and develop own models to meet domestic demand while increasing international footprint. "Let us move from 'Volume' to 'Value' leadership to capture global pharmaceutical market," an official statement said, quoting Mandaviya. He further said, "It is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop our own models focused on accelerating production to meet the domestic demand while increasing our global footprint." The minister also pushed for making the .

Dr Reddy's acquire Eton Pharma's injectable products for $50 million

Under the terms of the agreement, Dr Reddy's acquired the Eton portfolio for an upfront payment of approximately USD 5 million in cash, besides contingent payments of up to USD 45 million

Govt wants to ease compliance burden on pharma industry: Mandaviya

Mandaviya, who is also the Minister for Health and Family Welfare, said that the Narendra Modi-led government at the Centre is not only pro-poor and pro-farmer but "industry-friendly" as well

S&P lowers outlook for Jubilant Pharma to negative, sees weak performance

Operating performance may remain weak due to regulatory issues, says rating agency.

WPI effect: 800 key drugs likely to see 10% price rise in April

While the NPPA may allow a 10 per cent rise in prices of NLEM drugs based on WPI this year, the actual price rise could be less, say drug firms

How Indegene helps global pharma cos develop drugs faster amid Covid

Indegene uses AI and ML, and medical data mining to speed up digital transformation at top life sciences organisations

Biocon Biologics to go for IPO in 18-24 months: Kiran Mazumdar-Shaw

Biocon arm buys Viatris biosimilars biz for $3.2 billion

Make investments more attractive in pharma sector: Pre-Budget survey

A pre-budget expectations survey showed increasing demand for making investments more attractive in the pharmaceutical industry.

Domestic demand to drive pharma SMEs' growth in FY22: Crisil SME Tracker

March-May 2021 was a particularly good period for Indian formulators due to exceptional demand for drugs amid the second wave of Covid-19 infections.